ERIN MCMANUS-TOMANEK: Open Payments
NPI 1104425123 · SUN CITY WEST, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 49 payments from 15 companies in 2025. Trend: 2023 $1,445 · 2024 $1,337 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $282 |
| Sumitomo Pharma America, Inc. | 7 | $181 |
| ABBVIE INC. | 7 | $138 |
| INTUITIVE SURGICAL, INC. | 1 | $122 |
| Lilly USA, LLC | 5 | $71 |
| Boston Scientific Corporation | 2 | $59 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
Products named: GEMTESA, OTEZLA, Da Vinci Surgical System, REPATHA, WATCHMAN Access System, KISUNLA, SYNTHROID, KRYSTEXXA.
Industry payments across AZ — which companies pay providers there.
